Paul Celano MD FASCO

Oncology•Baltimore, MD

Gynecologic Cancer, Hematologic Oncology

Chief, Division of Medical Oncology, GBMC Assistant Professor Oncology &Gynecology, Johns Hopkins

Join to View Full Profile

6569 N Charles StSuite 201Baltimore, MD 21204
Phone+1 443-849-3051
Fax+1 443-849-3057

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1984 - 1987
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1981 - 1984
Icahn School of Medicine at Mount SinaiClass of 1981

Certifications & Licensure

MD State Medical License 1984 - 2026
PA State Medical License 1982 - 1988
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow of the American Society of Clinical Oncology American Society of Clinical Oncology, 2018
America's Top Doctors Castle Connolly, 2011-2014
America's Top Doctors for Cancer Castle Connolly, 2011-2013
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
Completed
Phase 2
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 Start of enrollment: 2023 Sep 22
RECRUITING
PHASE3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

6 citations
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.3.
Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano
Journal of Clinical Oncology. 2023-04-10
6 citations
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.3.
Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano
Journal of Clinical Oncology. 2023-04-10
25 citations
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2.
Dwight H Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano
Journal of Clinical Oncology. 2023-02-10

Press Mentions

Don’t Miss This: ASCO Webinar on Standards for Safely Handling Hazardous DrugsFebruary 7th, 2019

Grant Support

Regulation Of Growth Gene Expression By The PolyaminesNational Cancer Institute1990–1993

Professional Memberships

American Society of Clinical Oncology - ASCO
Member